Isis Pharma changes name to Ionis Pharma

Posted On Sep 16 2016 by

#isis pharma # From Isis Pharma to Ionis Isis Pharmaceuticals has changed its name to Ionis Pharmaceuticals, the Carlsbad biotech company announced Friday. With the new name — free of any similarities to the widely used acronym for the Islamic State terrorist group, comes a new stock ticker — IONS. That ticker goes into effect when trading opens on Dec. 22. The company is also getting a new website: www.ionispharma.com. But it wasn’t just the unsavory association that caused Isis to become Ionis, (pronounced “eye-OH-nis”) said Stanley T. Crooke, the company’s chairman and chief executive. It was the potential problems …


Biopharma

Posted On Sep 16 2016 by

#biopharma # Your project, our care Biopharma: production of ß-lactam antibiotics Orofino Sites Orofino Business Biopharma is a specialized manufacturer of Beta-Lactam antibiotics. The company was founded in 1989 by The Orofino Group and began the construction of the new Biopharma manufacturing site located at Santa Palomba in Rome, Italy. By 1995 it commenced commercial operations with the authorization from the regulatory authorities. As a result of a continual investment policy, the site has been kept up-to-date with the latest technologies and is now one of the most advanced in Europe. These technological capabilities, together with the high level of …


Jobs in pharmaceutical companies

Posted On Sep 16 2016 by

#jobs in pharmaceutical companies # Careers Pfizer Australia offers outstanding career opportunities within an organisation established as a premier employer of choice. Pfizer Australia is recognised for its excellence across all aspects of the healthcare business. Be it sales and marketing, research and development or manufacturing, our professionals are engaged in an environment where their talents, skills and drive for achievement are constantly in demand. Our track record of outstanding success has been fuelled by the dedication and dynamic nature of our people. Pfizer Australia is committed to the hiring, advancement and fair treatment of individuals without discrimination based on …


Tris Pharma, Inc

Posted On Sep 16 2016 by

#tris pharma # Tris Pharma, Inc. Latest Drug Information Updates Troxyca ER Troxyca ER (oxycodone hydrochloride and naltrexone hydrochloride) is an extended-release, abuse-deterrent. Adlyxin Adlyxin (lixisenatide) is a once-daily prandial glucagon-like peptide-1 (GLP-1) receptor agonist indicated. Xiidra Xiidra (lifitegrast) is a lymphocyte function-associated antigen-1 (LFA-1) antagonist indicated for the. Epclusa Epclusa (sofosbuvir and velpatasvir) is a nucleotide analog polymerase inhibitor and pan-genotypic NS5A. Byvalson Byvalson (nebivolol and valsartan) is a beta adrenergic blocker and an angiotensin II receptor blocker (ARB). Zinbryta Zinbryta (daclizumab) is an interleukin-2 receptor blocking antibody indicated for the treatment of relapsing. More. Was this page helpful? …


Pharmaceutical Packaging – Packaging Solutions for Drugs

Posted On Sep 16 2016 by

#pharma packaging solutions # A Drug is Only as Good as its Packaging Permits How secure are your packaging materials? In recent years, the pharmaceutical industry has been developing drugs that are increasingly sensitive. In order to protect these active ingredients. pharmaceutical packaging requirements were consistently increasing, too. Thanks to our comprehensive material and process expertise we develop packaging solutions for you that are individually tailored to the drug. We can thus offer your products optimal protection. The added value accruing from RAUMEDIC RAUMEDIC develops polymeric packaging solutions and expands them through individual functions that are tailored to your drug. …


FTC Sues Endo Pharmaceuticals Inc

Posted On Sep 16 2016 by

#endo pharma # FTC Sues Endo Pharmaceuticals Inc. and Others for Illegally Blocking Lower-Cost Generic Versions of the Branded Drugs Opana ER and Lidoderm The Federal Trade Commission filed a complaint in federal district court alleging that Endo Pharmaceuticals Inc. and several other drug companies violated antitrust laws by using pay-for-delay settlements to block consumers’ access to lower-cost generic versions of Opana ER and Lidoderm. Following more than a decade of FTC challenges to pay-for-delay settlements, today’s enforcement action is the first FTC case challenging an agreement not to market an authorized generic – often called a “no-AG commitment” – …


Tris Pharma Receives FDA Approval of Dyanavel™ XR (amphetamine) CII as Once-Daily Liquid for

Posted On Sep 16 2016 by

#tris pharma # Tris Pharma Receives FDA Approval of Dyanavel™ XR (amphetamine) CII as Once-Daily Liquid for Treatment of ADHD in Children MONMOUTH JUNCTION, N.J. Oct. 20, 2015 /PRNewswire/ — Tris Pharma, Inc. (“Tris”) announced that the U.S. Food and Drug Administration (“FDA”) has approved Dyanavel XR (amphetamine), extended-release oral suspension, CII, for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children 6 years and older. With this approval, Dyanavel XR becomes the only once-daily, extended release amphetamine-based oral liquid approved for the treatment of ADHD in children. The approval is based on a Phase III randomized, placebo-controlled, laboratory classroom efficacy …


Tris Pharma

Posted On Sep 16 2016 by

#tris pharma # Expand your market reach with Tris innovative technologies Protect your products from intentional and unintentional abuse News & Events Tris Pharma Announces the Launch of DYANAVEL XR (amphetamine) Extended-release Oral Suspension, CII for the Treatment of Children with ADHD (April 2016) Read More Tris Pharma Announces Appointment of Chief Commercial Officer of its New Brand Business (April 2016) Read More Tris Pharma Announces First Ever FDA-Approved Extended-Release Chewable Tablet (December 2015) Read More Pfizer Receives U.S. FDA Approval of New QuilliChew ER (methylphenidate hydrochloride) extended-release chewable tablets CII (December 2015) Read More Tris Pharma Receives FDA Approval …


NCBiotech Jobs Network- 7 Tips for Crafting an Eye-Catching LinkedIn Profile

Posted On Sep 16 2016 by

#biotechnology jobs # NCBiotech Jobs Network- 7 Tips for Crafting an Eye-Catching LinkedIn Profile With more the 450 million users, LinkedIn is the networking tool for business professionals. Most employers and hiring managers rely on LinkedIn to recruit and vet talent. Moreover, LinkedIn profiles often populate the top responses of a Google search, making your profile a perfect opportunity to market your skills, abilities, and experiences. At this session, Heidi Scott Giusto will focus on teaching you 7 tips that will help you take your profile to the next level. Heidi Scott Giusto, Ph.D. owns Career Path Writing Solutions and …


How to get a chemical engineer job in the pharmaceutical industry

Posted On Sep 16 2016 by

#jobs pharmaceutical industry # ProClinical Life Sciences Recruitment Blog Interested in the pharmaceutical industry? We don’t blame you. According to the World Health Organization, “the global pharmaceuticals market is worth US$300 billion a year, a figure expected to rise to US$400 billion within 3 years.” In other words, the pharmaceutical industry is booming, and the growth opportunities are truly endless. As a chemical engineer, you are an integral part to any pharmaceutical organisation. However, since the industry is so hot right now, getting your foot in the door can prove rather difficult. So, how do you get a job as …